Osmind
YC S20San Francisco, US · Founded 2020 · 55 employees · 3 known investors
Osmind is a public benefit corporation developing technology and research infrastructure to accelerate evidence-based mental health treatments, including therapies like ketamine, and to improve patient access to care.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMental HealthSaaSMental Health TechHealth Techin /65320902@OsmindHQ
Founders & leadership· Y Combinator alumni (S20)
Lucia HuanginFounder
Investors · 3
In the news
- Compass Pathways partners with Osmind on psychedelic treatment delivery By Investing.cominvesting.com · 2026
- Osmind CEO Lucia Huang went through Y Combinator and is disrupting the world of psychiatry - The Business Journalsbizjournals.com · 2024
- Lucia Huang: Destigmatizing Mental Health - UCSF Rosenman Instituterosenmaninstitute.org · 2023
- Innovative mental healthcare practices are hampered by access challenges, adminifiercehealthcare.com · 2023
- Osmind Raises $40M Series B Round Led by DFJ Growth to Expand Platform for Breakthrough Mental Health Research and Treatment | Healthcare IT Todayhealthcareittoday.com · 2022
- Osmind scores $40M investment to aid in mental health research and treatment - MedCity Newsmedcitynews.com · 2022
- A Beautiful (Os)mind. By Justin Kao, Barry Schuler, Jocelyn… | by DFJ Growth | DFJ Growth News | Mediummedium.com · 2022
- Osmind - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021